Appointments
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Executives On The Move: New Arrivals In Commercial For Exopharm And Primex, And A Departure At Grupo Biotoscana
For Exopharm, an Australian regenerative medicine firm, a new chief commercial officer, and for Primex Pharmaceuticals, a global anesthesia products company, a new head, global commercial. Over at Latin American advanced medicines business Grupo Biotoscana, a CEO resignation.
Executives On The Move: Financial Promotions To C-Suite Spots At Gilead and Amgen, And A VP Exits GSK For Achilles
Next month a promotion from EVP, development to CFO will take place at Gilead Sciences, and in the new year an EVP, Finance will assume the CFO spot at Amgen. Meanwhile, a VP will exit GSK to be CBO at personalized T-cell therapy firm Achilles Therapeutics.
Executives On The Move: Development Hires At BiomX And CytomX, Revance Chooses a CEO
Two new chief development officers: former Teva Pharma exec moves to microbiome-based therapeutics firm BiomX; and BioGene CMO makes a change to oncology biopharma CytomX. At Revance Therapeutics, a developer of therapeutic neuromodulators, a CEO is chosen.
Asia Executives On The Move: Senior Changes At Biogen, Amicus, PhRMA In Japan, Ascletis and Lupin
Executives On The Move: Everest Poaches From Big Pharma; Gilead Gets New CMO
China and Asia-focused Everest Medicines has poached a handful of senior hires from Sanofi, Abbott and Amgen, while Gilead Sciences’ new chief medical officer Merdad Parsey joins from Genentech.
Executives On The Move: New Leaders Fill C-Suite Positions At Midatech, Retrophin And Sangamo
Midatech Pharma and Retrophin – both developing therapies for rare diseases – appoint CFO and chief commercial officer, respectively. Meanwhile, genomic medicine company Sangamo Therapeutics hires a CMO.
Executives On The Move: Regional And Global Position Changes At SIFI, EMD Serono And Acino
EMD Serono welcomes SVP, North American medical affairs while ophthalmic products company SIFI SpA announces country manager, Italy and. At Acino International a new global head for IT is now on board.
Asia Executives On The Move: Senior Level Changes At Pfizer Upjohn, Simcere In China
Executives On The Move: Menarini Group Chooses Next CEO, Crescendo Decides On A CBO And Scholar Rock Adds Head, Medical Research
At Italian Biopharma Menarini Group a former Merck KGaA head of new business is now CEO. Oncology therapeutics firm Crescendo Biologics picks GSK exec as CBO and Biogen medical director is now a Medical Research Head at clinical-stage biopharma Scholar Rock.
Executives On The Move: New CEOs at RhoVac and Step Pharma
Recent appointments at executive level in pharmaceutical and biotech companies include new CEOs at RhoVac AB, Step Pharma and Ascendis Health, a new chief business officer at MaaT Pharma, and a new chief scientific officer at Pieris Pharmaceuticals.
Executives On The Move: Bayer Acquires Talent from J&J And Synlogic And Stealth Decide On Chief Positions
Former J&J exec joins Bayer AG as head, business development and licensing. Synthetic biotic medicines firm Synlogic welcomes a CMO and Stealth BioTherapeutics, which is developing candidates for treatment of mitochondrial dysfunction, adds a CFO.
Executives On The Move: Management Changes In Quality, Tech And Finance At Eisai, Frequency Therapeutics And Fresenius
Japanese pharma Eisai picks Merck Research exec as VP, Global Clinical Quality Assurance and former Moderna scientist joins regenerative med company Frequency Therapeutics in SVP, Technology Development slot. Meanwhile, Fresenius Medical Care announces CFO hire.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.